04:03 PM EDT, 06/04/2025 (MT Newswires) -- Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index up 0.6% and the Health Care Select Sector SPDR Fund (XLV) adding 0.2%.

The iShares Biotechnology ETF (IBB) increased 0.2%.

In corporate news, Biohaven ( BHVN ) shares popped 2.8% after the company said its two drug candidates are near market and it's doing phase three testing for four other indications.

Moleculin Biotech ( MBRX ) shares dropped almost 20% after it said no patients achieved complete response in a phase 1b/2 study of Annamycin to treat soft tissue sarcoma lung metastases.

Natera ( NTRA ) shares jumped 4.4% after the company said its Signatera Genome test is now covered by Medicare for several cancer types.

Sagimet Biosciences ( SGMT ) shares surged 12% after the company said denifanstat met primary and secondary endpoints in a phase 3 trial to treat moderate to severe acne vulgaris.

Neogen (NEOG) shares tumbled nearly 17% after the company said transitory headwinds are expected to hit Q4 gross margins.